Cite Filings / CTKB / 0001104659-22-033394

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Cytek Biosciences, Inc. Filed 2022-03-14 Acc 0001104659-22-033394

Documents 1

SC 13D/A Beneficial Ownership Report , tm229218-1_sc13da.htm

Around this filing

2023-09-19 SC 13D/A Beneficial Ownership Report
2022-03-17 S-8 Securities Offered to Employees in Benefit Plans
2022-03-17 10-K Annual Report
2022-03-16 4 Director bought 583,870 shares at an average $12.31 ($7,188,926)
2022-03-14 SC 13D/A Beneficial Ownership Report
2022-03-11 4 Director bought 634,638 shares at an average $12.86 ($8,158,671)
2022-02-28 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm229218-1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…